E D Rosenstein

Summary

Affiliation: Newark Beth Israel Medical Center
Country: USA

Publications

  1. ncbi request reprint Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis
    Elliot D Rosenstein
    Center for Rheumatic and Autoimmune Diseases, Livingston, New Jersey 07039, USA
    Inflammation 28:311-8. 2004
  2. ncbi request reprint Giant cell myocarditis: most fatal of autoimmune diseases
    E D Rosenstein
    Division of Rheumatology and Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, Livingston, NJ 07039, USA
    Semin Arthritis Rheum 30:1-16. 2000
  3. ncbi request reprint Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis
    Elliot D Rosenstein
    Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Prostaglandins Leukot Essent Fatty Acids 68:213-8. 2003
  4. doi request reprint A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
    I Sabnani
    Division of Hematology Oncology, Newark Beth Israel Medical Center, Newark, NJ 07112, USA
    Rheumatology (Oxford) 48:49-52. 2009
  5. ncbi request reprint Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin
    R M Van Solingen
    Department of Medicine, Saint Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Am J Med 111:285-9. 2001
  6. ncbi request reprint Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
    Neil Kramer
    St Barnabas Medical Center, Livingston, New Jersey, USA
    Arthritis Rheum 47:670-1. 2002

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis
    Elliot D Rosenstein
    Center for Rheumatic and Autoimmune Diseases, Livingston, New Jersey 07039, USA
    Inflammation 28:311-8. 2004
    ..PAD engendered antigens lead to production of rheumatoid factor-containing immune complexes and provoke local inflammation, both in gingiva and synovium via Fc and C5a receptors...
  2. ncbi request reprint Giant cell myocarditis: most fatal of autoimmune diseases
    E D Rosenstein
    Division of Rheumatology and Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, Livingston, NJ 07039, USA
    Semin Arthritis Rheum 30:1-16. 2000
    ..To increase awareness of giant cell myocarditis (GCM), its pathogenesis, and treatment...
  3. ncbi request reprint Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis
    Elliot D Rosenstein
    Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Prostaglandins Leukot Essent Fatty Acids 68:213-8. 2003
    ..Additional studies will be necessary to more fully assess the potential of these agents to favorably affect periodontal inflammation...
  4. doi request reprint A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
    I Sabnani
    Division of Hematology Oncology, Newark Beth Israel Medical Center, Newark, NJ 07112, USA
    Rheumatology (Oxford) 48:49-52. 2009
    ..g. cyclophosphamide (CYC) and imatinib (PDGFR inhibitor), might be useful for treating SSc-related ILD. Our objective was to evaluate the safety and efficacy of this combination therapy in scleroderma-related pulmonary disease...
  5. ncbi request reprint Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin
    R M Van Solingen
    Department of Medicine, Saint Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Am J Med 111:285-9. 2001
    ..Trials are warranted to determine whether these in vitro effects result in clinical antiplatelet activity in patients who require chronic treatment with NSAIDs, thereby avoiding the toxicity of NSAID/aspirin combination therapy...
  6. ncbi request reprint Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
    Neil Kramer
    St Barnabas Medical Center, Livingston, New Jersey, USA
    Arthritis Rheum 47:670-1. 2002